Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(α2-3)Gal

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 6, 2010, Pages 623-628

  Rojas Garcia, Ricard ^a,b   Gallardo, Eduard ^b,c   De Luna, Noemi ^b,c   Juarez, Candido ^c   Martinez Hernandez, Eugenia ^a,b   Carvajal, Alejandra ^d   Casasnovas, Carlos ^e   Fages, Eva ^f   Davila González, Pablo ^g   Illa, Isabel ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL SIERRALLANA   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f Allergy Section   (Spain)

^g HOSPITAL DE MANACOR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM3; GANGLIOSIDE GT 1B; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; N ACETYLNEURAMINIC ACID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; BULBAR; CLINICAL ARTICLE; CRANIAL NERVE; DYSARTHRIA; DYSPHAGIA; DYSPHONIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; THIN LAYER CHROMATOGRAPHY;

EID: 77953707990     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.183517     Document Type: Article

References (19)

1. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-625.
2. Oga T, Kusunoki S, Fujimura H, et al. Severe motor-dominant neuropathy with IgM M-protein binding to the NeuAcalpha2-3Galbeta moiety. J Neurol Sci 1998;154:4-7.
3. Mizutani K, Oka N, Kusunoki S, et al. Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3. J Neurol Sci 2001;188:9-11.
4. Rojas-Garcia R, Martinez-Lage M, Gallardo E, et al. A novel antiganglioside specificity against terminal NeuNAc(alfa 2-3)Gal in acute bulbar palsy. J Neuroimmunol 2006;176:219-22.
5. Rojas-Garcia R, Gallardo E, Povedano M, et al. Antibodies against disialosyl and terminal NeuNAc(alpha2-3)Gal ganglioside epitopes in acute relapsing sensory ataxic neuropathy. J Neurol 2008;255:764-6.
6. Brindel I, Preud'homme JL, Vallat JM, et al. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy. Neurosci Lett 1994;181:103-6.
7. Willison HJ, O'Leary CP, Veitch J, et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 2001;124:1968-77.
8. Willison HJ, Veitch J, Swan AV, et al. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 1999;6:71-7.
9. O'Hanlon GM, Veitch J, Gallardo E, et al. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies. Autoimmunity 2000;32:133-44.
10. Obi T, Kusunoki S, Takatsu M, et al. IgM M-protein in a patient with sensorydominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol Scand 1992;86:215-18.
11. Willison HJ, Paterson G, Veitch J, et al. Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry 1993;56:1178-83. (Pubitemid 23323657)
12. Koga M, Yuki N, Hirata K. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom. J Neurol Neurosurg Psychiatry 1999;66:513-16. (Pubitemid 29145689)
13. Yoshino H, Harukawa H, Asano A. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy. J Neuroimmunol 2000;105:195-201.
14. Onodera M, Mori M, Koga M, et al. Acute isolated bulbar palsy with anti-GT1a IgG antibody subsequent to Campylobacter jejuni enteritis. J Neurol Sci 2002;205:83-4.
15. O'Leary CP, Veitch J, Durward WF, et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996;61:649-51. (Pubitemid 27023349)
16. Koga M, Yoshino H, Morimatsu M, et al. Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 2002;72:767-71.
17. Koga M, Yuki N, Ariga T, et al. Is IgG anti-GT1a antibody associated with pharyngealcervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol 1998;86:74-9.
18. Kashihara K, Shiro Y, Koga M, et al. IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1998;65:799.
19. Nagashima T, Koga M, Odaka M, et al. Clinical correlates of serum anti-GT1a IgG antibodies. J Neurol Sci 2004;219:139-45.